Royal Bank of Canada’s Tenet Healthcare THC Stock Holding History

Royal Bank of Canada’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,000	Closed	-$1.05M	–	7525
2024 Q1	$1.05M	Buy	10,000 +5,000	+100%	+$449K	﹤0.01%	3429
2023 Q4	$378K	Buy	+5,000	New	+$317K	﹤0.01%	4518
2023 Q1	–	Sell	-25,000	Closed	-$1.22M	–	7471
2022 Q4	$1.22M	Hold	25,000	–	–	﹤0.01%	3335
2022 Q3	$1.29M	Hold	25,000	–	–	﹤0.01%	3217
2022 Q2	$1.31M	Hold	25,000	–	–	﹤0.01%	3254
2022 Q1	$2.15M	Hold	25,000	–	–	﹤0.01%	2992
2021 Q4	$2.04M	Hold	25,000	–	–	﹤0.01%	3140
2021 Q3	$1.66M	Hold	25,000	–	–	﹤0.01%	3236
2021 Q2	$1.68M	Buy	+25,000	New	+$1.55M	﹤0.01%	3213
2018 Q1	–	Sell	-60,000	Closed	-$910K	–	6780
2017 Q4	$910K	Hold	60,000	–	–	﹤0.01%	3302
2017 Q3	$986K	Buy	60,000 +45,000	+300%	+$763K	﹤0.01%	3236
2017 Q2	$290K	Sell	15,000 -252,500	-94%	-$4.4M	﹤0.01%	4091
2017 Q1	$4.74M	Buy	+267,500	New	+$4.96M	﹤0.01%	1951
2016 Q2	–	Sell	-40,000	Closed	-$1.16M	–	6521
2016 Q1	$1.16M	Hold	40,000	–	–	﹤0.01%	2926
2015 Q4	$1.21M	Buy	+40,000	New	+$1.31M	﹤0.01%	2953

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada's THC Position: Q1 2026 in Review

Royal Bank of Canada reduced its Tenet Healthcare (THC) stake by 16% in Q1 2026, selling an estimated $2.25M and leaving 57,685 shares worth $10.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1852.

Royal Bank of Canada first reported a position in THC in Q2 2013 and has held it in 52 quarters since. The position peaked at $61.4M in Q3 2025. 692 funds tracked by Wall St. Rank hold THC as of Q1 2026.

Royal Bank of Canada held 57,685 shares of Tenet Healthcare worth $10.9M as of Q1 2026.
Royal Bank of Canada sold 10,695 Tenet Healthcare shares in Q1 2026, an estimated $2.25M.
Tenet Healthcare made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1852 holding.
Royal Bank of Canada first reported a position in Tenet Healthcare in Q2 2013 and has held it in 52 quarters since.
Royal Bank of Canada's Tenet Healthcare position peaked at $61.4M in Q3 2025.
692 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.